NCT00334074
- Conditions
- Acute Myelogenous Leukemia, Blast Crisis, Bone Marrow Diseases, +19 more
- Locations
-
- Baylor University Medical Center Dallas, Texas, United States
Clinical trial condition
Chronic Myelogenous Leukemia
Explore clinical trials studying Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.
112 public trials
10 recruiting studies
Chronic Myelogenous Leukemia trial results
NCT00697671
- Conditions
- Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +28 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Completed
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
NCT00807677
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Polycythemia, +47 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States
NCT00719836
- Conditions
- Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +19 more
- Locations
-
- The University of Chicago Hospitals Chicago, Illinois, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Fred Hutchinson Cancer Center Seattle, Washington, United States
NCT00270881
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +24 more
- Locations
-
- Keio University School of Medicine Tokyo, Japan
NCT00493181
- Conditions
- Blood Platelet Disorders, Bone Marrow Diseases, Chronic Disease, +15 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00144677
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +28 more
- Locations
-
- Dana-Farber Cancer Center Boston, Massachusetts, United States
NCT00088231
- Conditions
- Acute Myelogenous Leukemia, Agnogenic Myeloid Metaplasia, Blast Crisis, +19 more
- Locations
-
- M.D. Anderson Cancer Center Houston, Texas, United States
NCT01003054
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Completed
Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
NCT00101647
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +12 more
- Locations
-
- Local Institution Birmingham, Alabama, United States
- Local Institution Anaheim, California, United States
- Local Institution Los Angeles, California, United States
- Local Institution Stanford, California, United States